Marc Tessier-Lavigne and David Baker are in the database as key figures around Xaira Therapeutics.
Xaira lists Tessier-Lavigne as chairman and CEO. Its launch announcement described him as founding CEO and said the company was co-founded by Baker.
Baker's University of Washington lab is central to modern protein design, including work such as RFdiffusion and RFantibody.